Tradestie Institutional Equity Comparison Engine

ZURA vs CAMP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CAMP Overall Edge

CAMP Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CAMP4 Therapeutics Corporation Common Stock (CAMP) driven by superior Momentum & Technical, Options & Structure while ZURA counters with relative strength in Growth & Margin. Fundamentally, ZURA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, ZURA sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ZURA N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner ZURA
Op Margin 0.0% vs -991.8% ยท YoY +0.0% vs +138.9%
Momentum & Technical Winner CAMP
1Y -75.4% vs -2.4% ยท 52W Pos 1% vs 23%
Options & Structure Winner CAMP
BREAKDOWN (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
ZURA NASDAQ
Zura Bio Limited Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.00
-6.94% 1D
Market Cap $119.4M
1M Return -73.62%
1Y Return -75.37%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 45.0 Fund 58.0 Flow 70.0 Mom 65.0
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
1M Return +27.39%
1Y Return -2.44%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZURA -75.37% CAMP -2.44% Spread: +72.93 pp (CAMP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZURA TTM Op. Margin: 0.0% CAMP TTM Op. Margin: -991.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZURA vs CAMP. Trailing 12-month operating profitability (ZURA 0.0% vs CAMP -991.8%) and valuation multiples (ZURA N/M vs CAMP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZURA (3) vs CAMP (4)
Institutional Metric ZURA CAMP Criterion Row Winner
Market Capitalization Scale $119.4M $238.5M Larger Scale CAMP
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +138.9% Higher Growth CAMP
Operating Margin (TTM) Profitability 0.0% -991.8% Higher Margin ZURA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -63.2% -146.1% Higher ROE ZURA
52-Week Range Position Momentum 1% ($1โ€“$7) 23% ($3โ€“$8) Stronger Trend CAMP
Beta / 30D Volatility Risk Regime 0.56ฮฒ ยท 272% Vol 1.35ฮฒ ยท 94% Vol Lower Realized Risk CAMP
Unified Institutional Score Composite Signal 46.3 / 100 (HOLD) 43.9 / 100 (HOLD) Higher Composite ZURA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZURA vs CAMP Buy Guide
ZURA BREAKDOWN
59d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ZURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZURA nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.